Tianjin Tasly Pride Pharmaceutical

Tianjin Tasly Pride Pharmaceutical is a specialized chemical drug subsidiary of the Tasly Pharmaceutical Group, based in Tianjin, China. The company focuses on the development, production, and international marketing of high-quality generic pharmaceuticals, particularly in the cardiovascular, oncology, and digestive health sectors. It is notable for being one of the first Chinese pharmaceutical companies to receive US FDA and EU GMP certifications for its oral solid dosage manufacturing facilities. Tasly Pride plays a pivotal role in the parent group's global strategy by producing medications that meet stringent international regulatory standards for export to highly regulated markets. Its portfolio includes key products such as Temozolomide and Rivaroxaban, reflecting its technical capability in complex chemical synthesis and formulation.